InterVax Tool statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.

Subscribe
info

Citations per year

Citations chart
info

Popular tool citations

chevron_left Vaccine candidate prediction chevron_right
Popular tools chart
info

Tool usage distribution map

Tool usage distribution map
info

Associated diseases

Associated diseases

InterVax Tool specifications

Information


Unique identifier OMICS_26847
Name InterVax Tool
Interface Web user interface
Restrictions to use None
Computer skills Basic
Stability Stable
Maintained Yes

Documentation


Maintainer


  • person_outline Steven Bellan <>

Publication for InterVax Tool

InterVax Tool institution(s)
Department of Epidemiology and Biostatistics, University of Georgia, Athens, GA, USA; Center for Ecology of Infectious Diseases, University of Georgia, Athens, GA, USA; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; World Health Organization, Geneva, Switzerland; Department of Biostatistics, University of Florida, Gainesville, FL, USA; Department of Geography, University of Kentucky, Lexington, KY, USA; Kenya Medical Research Institute, Centre for Vector Biology and Control Research, Kisumu, Kenya; Centre de recherche du CHU de Québec, Quebec, QC, Canada; Département de médecine sociale et préventive, Université Laval, Québec, QC, Canada; Department of Infectious Disease Epidemiology, Imperial College, London, UK; US Centers for Disease Control and Prevention, Atlanta, GA, USA
InterVax Tool funding source(s)
Supported by National Institute of Health (NIH) National Institute of Allergy, Infectious Diseases grant K01AI125830; the National Institute for Health Research through the Health Protection Research Unit in Immunisation at the London School of Hygiene & Tropical Medicine in partnership with Public Health England, the Innovative Medicines Initiative 2 (IMI2) Joint Undertaking under grant agreement EBOVAC1 (grant 115854); the European Union Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations; by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant 206250/Z/17/Z); the National Institutes of Health (NIH) grant R37-AI032042 and WHO funding.

InterVax Tool reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review InterVax Tool